ResearcherSt. Jude Children's Research HospitalNo recent work listed

Peter O. Oladimeji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2050-5949; OpenAlex author ID A5056131713. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

KANSL2 and MBNL3 are regulators of pancreatic ductal adenocarcinoma invasion. Co-author DOI 10.1038/s41598-020-58448-y ↗
Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells. Co-author DOI 10.1186/s12885-019-5455-1 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jesse Bakke · 2 shared papers, 2019–2020 · strength 0.26
- Paper KANSL2 and MBNL3 are regulators of pancreatic ductal adenocarcinoma invasion. DOI 10.1038/s41598-020-58448-y ↗
- Paper Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells. DOI 10.1186/s12885-019-5455-1 ↗
Taosheng Chen · 2 shared papers, 2019–2020 · strength 0.26
- Paper KANSL2 and MBNL3 are regulators of pancreatic ductal adenocarcinoma invasion. DOI 10.1038/s41598-020-58448-y ↗
- Paper Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells. DOI 10.1186/s12885-019-5455-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.